section name header

Table 110.1

Adjuvant Analgesics

Class of drugsIndicationExampleAdverse effects/comments
Non-steroidal anti- inflammatory drugs (NSAIDs)

Inflammation

Bone metastases

Soft tissue infiltration

Individual drug choice based on patient's risk factors and adverse effect profile of drug

Use PPI cover

Peptic ulceration, bleeding and perforation

Arterial thrombosis

Renal impairment

Fluid retention

Avoid in elderly

Steroids

Inflammation

Soft tissue infiltration

Bone metastases

Nerve compression

Liver capsule pain

Raised intracranial pressure

Dexamethasone (4–8 mg daily, morning dose to reduce insomnia)

Titrate down to lowest dose that controls pain

Short course with PPI cover

GI irritation and bleeding

Fluid retention

Cushingoid appearance

Diabetes

Candidiasis

Osteoporosis

Anti-muscarinicsSmooth muscle colicHyoscine butylbromideDry mouth, constipation, urinary retention, blurred vision, flushing, tachycardia
BisphosphonatesPainful bone metastasesVarious regimens (usually IV infusion)

Hypocalcaemia

Flu-like symptoms

Osteonecrosis of the jaw (need dental review before commencing)

Neuropathic agents
Gabapentin

Neuropathic pain

(Anticonvulsant)

300 mg PO with starting dose at night and titrate by 300 mg/24h every 2–3 days

(Slower titration in elderly/frail: 100 mg at night and titrate by 100 mg/24h every 2–3 days)

Mild sedation

Tremor

Confusion

Reduce dose in renal impairment

Pregabalin

Neuropathic pain

(Anticonvulsant)

75 mg 12-hourly PO starting dose and titrate at intervals of 3–7 days,in debilitated patients start with 25 –50 mg BD.

Dizziness, drowsiness (usually improve)

Confusion, tremor, dry mouth

Reduce dose in renal impairment

Amitriptyline

Neuropathic pain

(antidepressant)

10 mg PO with starting dose at night and titrate up after 3–7 days if tolerated

Sedation, dizziness, confusion, dry mouth, constipation, urinary retention

Caution in heart failure